A conversation with Novartis Chief Digital Officer Bertrand Bodson

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

Caring for a baby with retinopathy of prematurity (ROP) has never been easy. But mother and social visionary Silke Mader has made it her life’s work to ensure that parents dealing with ROP and other complications today get more support than she did.

Compound offers a potential tool for fighting drug-resistant malaria parasites.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.